Nan Fung Group Holdings LTD Rani Therapeutics Holdings, Inc. Put Options Transaction History
Nan Fung Group Holdings LTD
- $52.7 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
45Shares Held
6.32MCall Options Held
29.4KPut Options Held
0-
Armistice Capital, LLC New York, NY3.15MShares$1.67 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA800KShares$423,8290.0% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$160,4530.02% of portfolio
-
Geode Capital Management, LLC Boston, MA191KShares$100,9950.0% of portfolio
-
Kestra Private Wealth Services, LLC156KShares$82,7540.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $13M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...